Stock A042520 HANSBIOMED CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Highlights HansBiomed Corporation

Equities

A042520

KR7042520007

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 04/06/2024 am IST 		5-day change 1st Jan Change
12,720 KRW -1.01% Intraday chart for HansBiomed Corporation -2.83% -13.35%
14/05 HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
14/02 HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CI
HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
CI
HansBiomed Corporation's Equity Buyback announced on June 23, 2022, has expired with 202,283 shares, representing 2.08% for KRW 1,986.65 million.
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
CI
HansBiomed Corporation's Equity Buyback announced on January 17, 2022, has expired with 246,000 shares, representing 2.46% for KRW 2,962.2 million.
CI
HansBiomed Corporation announces an Equity Buyback for KRW 2,000 million worth of its shares.
CI
HansBiomed Corporation authorizes a Buyback Plan.
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
CI
HansBiomed Corporation announces an Equity Buyback for KRW 3,000 million worth of its shares.
CI
HansBiomed Corporation authorizes a Buyback Plan.
CI
HansBiomed Corporation's Equity Buyback announced on March 20, 2020, has expired.
CI
HansBiomed Corporation announces an Equity Buyback for 200,000 shares.
CI
HansBiomed Corporation authorizes a Buyback Plan.
CI
Midas International Asset Management acquired 6.5% stake in Hans Biomed Corporation.
CI
Partners Win-Win Growth Private Equity Fund 3 acquired 6.18% stake in Hans Biomed Corporation.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A042520 Stock
  4. News HansBiomed Corporation
  5. Highlights